Report Library
View More
Datamonitor Healthcare CNS Disease ...
May 21, 2025
Datamonitor Healthcare I&I: Opioid-...
May 21, 2025
Gene, Cell, & RNA Therapy Landscape...
May 16, 2025
Epilepsy KOL Interview - France
May 16, 2025
Datamonitor Healthcare Oncology: Pa...
May 15, 2025
Datamonitor Healthcare Infectious D...
May 15, 2025
Datamonitor Healthcare Infectious D...
May 14, 2025
Datamonitor Healthcare CNS: Insomni...
May 13, 2025
Wet AMD KOL- US, South #2
May 12, 2025
Datamonitor Healthcare Oncology Dis...
May 9, 2025
Datamonitor Healthcare Oncology: NH...
May 30, 2025
Datamonitor Healthcare Oncology: My...
May 29, 2025
HIV Pre-Exposure Prophylaxis (HIV P...
May 27, 2025
HIV Pre-Exposure Prophylaxis (HIV P...
May 27, 2025
HIV Pre-Exposure Prophylaxis (HIV P...
May 27, 2025
Datamonitor Healthcare Oncology: Ho...
May 27, 2025
Datamonitor Healthcare Other: Uteri...
May 27, 2025
2025 Biomedtracker Datamonitor Hea...
May 23, 2025
Ovarian Cancer - KOL Interview - US...
May 21, 2025
Datamonitor Healthcare Oncology Dis...
May 21, 2025
Datamonitor Healthcare CNS Disease ...
May 21, 2025
Datamonitor Healthcare I&I: Opioid-...
May 21, 2025
Gene, Cell, & RNA Therapy Landscape...
May 16, 2025
Epilepsy KOL Interview - France
May 16, 2025
Datamonitor Healthcare Oncology: Pa...
May 15, 2025
Datamonitor Healthcare Infectious D...
May 15, 2025
Datamonitor Healthcare Infectious D...
May 14, 2025
Datamonitor Healthcare CNS: Insomni...
May 13, 2025
Wet AMD KOL- US, South #2
May 12, 2025
Datamonitor Healthcare Oncology Dis...
May 9, 2025
Datamonitor Healthcare Oncology: NH...
May 30, 2025
Datamonitor Healthcare Oncology: My...
May 29, 2025
HIV Pre-Exposure Prophylaxis (HIV P...
May 27, 2025
HIV Pre-Exposure Prophylaxis (HIV P...
May 27, 2025
HIV Pre-Exposure Prophylaxis (HIV P...
May 27, 2025
Datamonitor Healthcare Oncology: Ho...
May 27, 2025
Datamonitor Healthcare Other: Uteri...
May 27, 2025
2025 Biomedtracker Datamonitor Hea...
May 23, 2025
Ovarian Cancer - KOL Interview - US...
May 21, 2025
Datamonitor Healthcare Oncology Dis...
May 21, 2025
Impact Events
More| Date | Lead Company | Event | Type | Approval Change | Approval Likelihood |
|---|---|---|---|---|---|
| 6/1/25 | Bristol (BMY) | Opdivo for Head and Neck Cancer | Subscribers Only | Subscribers Only | Subscribers Only |
| 6/1/25 | AstraZeneca (AZN) | Camizestrant for HR+/HER2- Breast Cancer | Subscribers Only | Subscribers Only | Subscribers Only |
| 6/1/25 | AstraZeneca (AZN) | Imfinzi for Gastric Cancer | Subscribers Only | Subscribers Only | Subscribers Only |
| 6/1/25 | Bristol (BMY) | Krazati for Non-Small Cell Lung Cancer (NSCLC) | Subscribers Only | Subscribers Only | Subscribers Only |
| 6/1/25 | Merck KGaA (MKKGY) | Bavencio for Bladder Cancer | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
More| Expected Date Range | Lead Company | Drug | Expected Catalyst |
|---|---|---|---|
| 04/01/2025 | Subscribers Only | Subscribers Only | Company - Divestment/Spinoff |
| 04/24/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 05/12/2025 | Subscribers Only | Subscribers Only | Trial Data - Other |
| 05/20/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 05/22/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |